Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis

European Journal of Ophthalmology

Volumn 6, Issue 4, 1996, Pages 361-367

  Shulman, D G ^a   Sargent, J B ^b   Stewart, R H ^c   Mester, U ^d  

^a Eye Care ^*  (United States)

^b Texas Eye Care   (United States)

^c Houston Eye Associates   (United States)

^d Bundesknappschaft's Hospital   (Germany)

Author keywords

antibiotic steroid combination; blepharitis; conjunctivitis; dexamethasone; neomycin; polymyxin B

Indexed keywords

DEXAMETHASONE; MAXITROL; NEOMYCIN; POLYMYXIN B;

ADULT; AGED; ARTICLE; BLEPHARITIS; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

EID: 0030475747     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219600600403     Document Type: Article

References (24)

1. Chusid MJ, Davis SD. Pathogenesis of corneal and conjunctival infections. In: Tabbara KF, Hyndiuk RA, eds. Infections of the Eye, 1st ed. Boston: Little Brown and Co 1986; 45-62.
2. Arffa RC. Conjunctivitis I: follicular, neonatal and bacterial. In: Arffa RC, ed. Grayson's Diseases of the Cornea, 3rd ed. St. Louis: Mosby Year Book, Inc. 1991; 103-132.
3. Fedukowicz HB, Stenson S. External Infections of the Eye: bacterial, viral, mycotic with non-infectious and immunologidiseases, 3rd ed. Norwalk: Appleton-Century-Crofts 1985; 1-118.
4. Glasser DB, Hyndiuk RA. Antibacterial agents. In: Tabbara KF, Hyndiuk RA, eds. Infections of the Eye, 1st ed. Boston: Little Brown and Co 1986; 211-238.
5. Jaanus SD. Anti-inflammatory drugs. In: Bartlett JD, Jaanus SD, eds. Clinical Ocular Pharmcology, 2nd ed. Boston: Butterworths 1989; 163-197.
6. Pappa KS. Corticosteroid drugs. In: Mauger TF, Craig EL, eds. Havener's Ocular Pharmacology, 6th ed. St. Louis: CV Mosby 1994, 364-414.
7. Bettman JW, Aronson SB, Kagawa CM, Hinson DB. The incidence of adverse reactions from steroid/antibiotic combinations. Surv Ophthalmol 1976; 20: 281-290.
8. Leibowitz HM, Kupferman A. Anti-inflammatory medications. Clinical pharmacology of the anterior segment. Ophthalmol Clin 1980; 20: 117-134.
9. Yolton DP. Anti-infective drugs. In: Bartlett JD, Jaanus SD, eds. Clinical Ocular Pharmacology, 2nd ed. Boston: Butterworths 1989; 199-244.
10. Mahajan VM. Postoperative ocular infections: an analysis of laboratory data on 750 cases. Ann Ophthalmol 1984; 16: 847-848.
11. Ashley KC. The anti-bacterial activity of topical anti-infective eye preparations. Med Lab Sci 1986; 43: 157-162.
12. Atkinson BA. Species incidence and trends of susceptibility to antibiotics in the United States and other countries: MIC and MBC. In: Lorian V, ed. Antibiotics in Laboratory Medicine, 2nd ed. Baltimore: Williams & Wilkins 1986; 995 and 1097-1098.
13. Ballows A, Hausler Jr WJ, Hermann KL, Isenberg HD, Shadomy, eds. Manual of Clinical Microbiology, 5th ed. Washington DC: American Society for Microbiology 1991.
14. Baron EJ, Finegold SM. Bailey and Scott's Diagnostic Microbiology. St Louis: CV Mosby Co 1990.
15. Koneman EW, Allen Dawell Jr VR, Janda WM, Sommers HM, Winn Jr WC. Color atlas and textbook of diagnostic microbiology, 3rd ed. Philadelphia: J.B. Lippincott Co 1988.
16. Kreig NR, Holt JG, eds. Bergey's manual of systematic bacteriology, vol 1. Baltimore: Williams & Wilkins 1984.
17. Sneath PHA, Mair NS, Sharpe ME, Holt JD, eds. Bergey's manual of systematic bacteriology, vol 2. Baltimore: Williams & Wilkins 1986.
18. Aragones JV. The treatment of blepharitis: controlled double-blind study of combination therapy. Ann Ophthalmol 1973; 5: 49-52.
19. Maxwell E, Aijian KM. Maxitrol suspension and ointment: clinical evaluation of two antibiotic-steroid preparations. Curr Ther Res 1964; 6: 130-133.
20. Leibowitz HM, Pratt MV, Flagstad IJ, Berrospi AR, Kundsin R. Human conjunctivitis I & II. Arch Ophthalmol 1976; 94: 1747-1756.
21. Stewart RH, Kimbrough RL, Smith JP, DeFaller JM. Use of steroid-antibiotic prophylaxis in intraocular lens implantation: a double-masked study. Ann Ophthalmol 1983; 15: 24-28.
22. Stern GA, Killingsworth DW. Complications of topical antimicrobial agents. Int Ophthalmol Clin 1989; 29: 137-142.
23. Burstein NL. Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 1980; 25: 15-30.
24. Wilson II FM. Adverse external ocular effects of topical ophthalmic medications. Surv Ophthalmol 1979; 24: 57-88.